Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
Clinical trial NCT05271162 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05271162
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-30
- Primary completion
- 2028-01-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.